Lam Research Corp. (Nasdaq: LRCX) today introduced Akara®, a breakthrough innovation in plasma etch and the most advanced ...

We expect Lam to focus on generating strong cash flow while prioritizing its R&D investments. We also expect it to remain moderately leveraged. As of June, Lam held a net cash position, with $5.8 ...

Lam Research Corp. (Nasdaq: LRCX) today unveiled ALTUS® Halo, the world's first atomic layer deposition (ALD) tool that ...

Feb. 19, 2025 /PRNewswire/ -- Lam Research Corp. (Nasdaq ... Akara joins Lam's differentiated product portfolio that empowers chipmakers to overcome the industry's hardest scaling challenges.

Here's a closer look at recent results from these two companies to see if selling Adobe or acquiring Lam Research could be a smart move for your portfolio ... alternatives to Adobe's most popular ...

Akara extends decades of Lam leadership in conductor etch. This includes multiple generations of the company's highly ...

Today's introductions of Akara and the separately announced ALTUS Halo, the world's first molybdenum atomic layer deposition ...

ALTUS Halo is the newest addition to Lam's ALTUS product family and is part of a differentiated product portfolio that ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...